Webinar: Plenty to fight for in CRISPR IP battle

Despite a recent swing in momentum to the University of California (UC), it’s still too early to say who is likely to emerge triumphant in the CRISPR patent battle.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Genetics

Charpentier CRISPR patent gets good news from Japan

14 December 2023 Novelty and inventive step of patent owned by ERS Genomics and Emmanuelle Charpentier withstand challenge at Japan Patent Office | Invalidity proceedings also rejected by JPO in 2021.

Genetics

Will de-extinct animals be patent eligible in the US?

5 January 2023 Science fiction is becoming science fact but the Alice/Mayo framework throws up some interesting challenges to bringing life back from the dead, explains Brian Hausman of Baker Botts.

Genetics

Gene-editing bill: encouraging innovation or adding complexity?

26 May 2022 UK legislation to streamline gene-editing technology research is promising for innovation, but presents potential complications for IP, finds Sarah Speight.

More features

Merchant & Gould hires 13 attorneys to open new Boston office

Novo Nordisk secures China win ahead of key patent expiration

Edwards v Meril: Inside the UPC’s landmark medtech showdown

Bird & Bird targets Nordic life sciences growth with regulatory hire

PTAB year in review: A shifting landscape and outlook for 2026

UPC: A review of 2025 and what to expect in 2026

Mental health in IP: ‘We have a clear picture of the problem’

From Edwards to Insulet: Three key medical device cases of 2025

Webinar: Plenty to fight for in CRISPR IP battle

More on this story

Editor's picks

Editor's picks

More features